GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosyntech Inc (OTCPK:BSYI) » Definitions » Cyclically Adjusted Price-to-FCF

Biosyntech (Biosyntech) Cyclically Adjusted Price-to-FCF : (As of Apr. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biosyntech Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Biosyntech Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Biosyntech's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyntech Cyclically Adjusted Price-to-FCF Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biosyntech's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Biosyntech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyntech's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biosyntech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Biosyntech's Cyclically Adjusted Price-to-FCF falls into.



Biosyntech Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Biosyntech's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2009 is calculated as:

For example, Biosyntech's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2009 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2009 (Change)*Current CPI (Dec. 2009)
=-0.014/90.7032*90.7032
=-0.014

Current CPI (Dec. 2009) = 90.7032.

Biosyntech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
199903 0.000 72.689 0.000
200006 -0.037 75.454 -0.044
200009 -0.021 75.928 -0.025
200012 -0.039 76.402 -0.046
200103 -0.028 76.719 -0.033
200106 -0.043 77.983 -0.050
200109 0.018 77.904 0.021
200112 -0.061 76.956 -0.072
200203 -0.015 78.141 -0.017
200206 -0.018 78.931 -0.021
200209 -0.022 79.721 -0.025
200212 0.025 79.879 0.028
200303 -0.522 81.459 -0.581
200306 -0.014 80.985 -0.016
200309 -0.018 81.459 -0.020
200312 0.023 81.538 0.026
200403 -0.046 82.091 -0.051
200406 -0.020 83.039 -0.022
200409 -0.020 82.960 -0.022
200412 0.025 83.276 0.027
200503 -0.070 83.987 -0.076
200506 -0.022 84.461 -0.024
200509 -0.032 85.647 -0.034
200512 -0.024 85.015 -0.026
200603 -0.053 85.805 -0.056
200606 -0.017 86.516 -0.018
200609 -0.015 86.279 -0.016
200612 -0.021 86.437 -0.022
200703 -0.019 87.780 -0.020
200706 -0.023 88.412 -0.024
200709 -0.021 88.412 -0.022
200712 -0.017 88.491 -0.017
200803 -0.026 88.965 -0.027
200806 -0.019 91.177 -0.019
200809 -0.027 91.414 -0.027
200812 -0.024 89.518 -0.024
200903 -0.019 90.071 -0.019
200906 -0.017 90.940 -0.017
200909 -0.018 90.624 -0.018
200912 -0.014 90.703 -0.014

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biosyntech  (OTCPK:BSYI) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Biosyntech Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Biosyntech's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyntech (Biosyntech) Business Description

Industry
Traded in Other Exchanges
N/A
Address
475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.

Biosyntech (Biosyntech) Headlines

No Headlines